1. Home
  2. ARMP vs CFBK Comparison

ARMP vs CFBK Comparison

Compare ARMP & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.34

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Logo CF Bankshares Inc.

CFBK

CF Bankshares Inc.

N/A

Current Price

$33.85

Market Cap

228.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ARMP
CFBK
Founded
N/A
1892
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
228.3M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
ARMP
CFBK
Price
$3.34
$33.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $17.50
N/A
AVG Volume (30 Days)
★ 257.6K
27.5K
Earning Date
11-11-2026
11-02-2026
Dividend Yield
N/A
★ 1.06%
EPS Growth
N/A
★ 30.58
EPS
N/A
★ 1.67
Revenue
N/A
N/A
Revenue This Year
N/A
$7.47
Revenue Next Year
N/A
$12.06
P/E Ratio
★ N/A
$20.43
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$22.10
52 Week High
$14.98
$38.11

Technical Indicators

Market Signals
Indicator
ARMP
CFBK
Relative Strength Index (RSI) 35.95 38.47
Support Level N/A $33.84
Resistance Level $5.63 $33.97
Average True Range (ATR) 0.49 0.76
MACD -0.08 -0.11
Stochastic Oscillator 5.26 4.56

Price Performance

Historical Comparison
ARMP
CFBK

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About CFBK CF Bankshares Inc.

CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.

Share on Social Networks: